Generate:Biomedicines to begin global phase 3 studies of GB-0895, a long-acting anti-TSLP antibody for severe asthma engineered with AI: Somerville, Massachusetts Tuesday, Decembe ...

Experiencing breathlessness when lying down, known as orthopnea, is a significant symptom often indicating heart or lung issues. This condition, where ...

Former Bangladesh Prime Minister Khaleda Zia is hospitalised in critical condition after developing a severe chest and lung ...

A Chinese Phase IIb trial of the mAb has already started, with Mabwell also hoping to initiate a Phase IIa trial in the US.

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced the completion of its Phase IIa clinical study for 9MW1911, a self-developed ...

TSRA-196 is a potential one-time treatment to precisely correct the genetic mutation underlying AATD, with Investigational New Drug filing ...

SOLAIRIA-1 and SOLAIRIA-2 will evaluate GB-0895 in approximately 1,600 patients with severe asthma whose disease remains ...

Cipla Launches India's First Integrated Lung Wellness Centre in Delhi - Cipla launches India’s first fully integrated ...

We need to support all tobacco and nicotine users and help them quit, become tobacco-free and nicotine-free - and protect others from such deadly products. Also, we have to ensure that we are ...

Non-Cystic Fibrosis Bronchiectasis Treatment Market to Reach USD 3.5 Bn by 2035 at 5.8% CAGR, Driven by rising disease burden ...

Lung diseases are a major global health concern. Many conditions begin silently with subtle signs. Early detection of ...

The international WAYFINDER trial – led by King’s College London – has shown that for severe asthma patients the use of ...